383 related articles for article (PubMed ID: 17071720)
1. IL-23 mediates inflammatory responses to mucoid Pseudomonas aeruginosa lung infection in mice.
Dubin PJ; Kolls JK
Am J Physiol Lung Cell Mol Physiol; 2007 Feb; 292(2):L519-28. PubMed ID: 17071720
[TBL] [Abstract][Full Text] [Related]
2. Mucoid Pseudomonas aeruginosa and regional inflammation in the cystic fibrosis lung.
Malhotra S; Hayes D; Wozniak DJ
J Cyst Fibros; 2019 Nov; 18(6):796-803. PubMed ID: 31036488
[TBL] [Abstract][Full Text] [Related]
3. Microbial pathogenesis in cystic fibrosis: pulmonary clearance of mucoid Pseudomonas aeruginosa and inflammation in a mouse model of repeated respiratory challenge.
Yu H; Hanes M; Chrisp CE; Boucher JC; Deretic V
Infect Immun; 1998 Jan; 66(1):280-8. PubMed ID: 9423869
[TBL] [Abstract][Full Text] [Related]
4.
Brao KJ; Wille BP; Lieberman J; Ernst RK; Shirtliff ME; Harro JM
Infect Immun; 2020 Aug; 88(9):. PubMed ID: 32631918
[TBL] [Abstract][Full Text] [Related]
5. Pseudomonas aeruginosa alginate is refractory to Th1 immune response and impedes host immune clearance in a mouse model of acute lung infection.
Song Z; Wu H; Ciofu O; Kong KF; Høiby N; Rygaard J; Kharazmi A; Mathee K
J Med Microbiol; 2003 Sep; 52(Pt 9):731-740. PubMed ID: 12909647
[TBL] [Abstract][Full Text] [Related]
6. Pseudomonas aeruginosa exploits lipid A and muropeptides modification as a strategy to lower innate immunity during cystic fibrosis lung infection.
Cigana C; Curcurù L; Leone MR; Ieranò T; Lorè NI; Bianconi I; Silipo A; Cozzolino F; Lanzetta R; Molinaro A; Bernardini ML; Bragonzi A
PLoS One; 2009 Dec; 4(12):e8439. PubMed ID: 20037649
[TBL] [Abstract][Full Text] [Related]
7. Prolonged inflammatory response to acute Pseudomonas challenge in interleukin-10 knockout mice.
Chmiel JF; Konstan MW; Saadane A; Krenicky JE; Lester Kirchner H; Berger M
Am J Respir Crit Care Med; 2002 Apr; 165(8):1176-81. PubMed ID: 11956064
[TBL] [Abstract][Full Text] [Related]
8. Role of Cftr genotype in the response to chronic Pseudomonas aeruginosa lung infection in mice.
van Heeckeren AM; Schluchter MD; Drumm ML; Davis PB
Am J Physiol Lung Cell Mol Physiol; 2004 Nov; 287(5):L944-52. PubMed ID: 15246977
[TBL] [Abstract][Full Text] [Related]
9. Neutrophils from F508del cystic fibrosis patients produce IL-17A and express IL-23 - dependent IL-17RC.
Taylor PR; Bonfield TL; Chmiel JF; Pearlman E
Clin Immunol; 2016 Sep; 170():53-60. PubMed ID: 27155366
[TBL] [Abstract][Full Text] [Related]
10. Estrogen aggravates inflammation in Pseudomonas aeruginosa pneumonia in cystic fibrosis mice.
Wang Y; Cela E; Gagnon S; Sweezey NB
Respir Res; 2010 Nov; 11(1):166. PubMed ID: 21118573
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-17 Pathophysiology and Therapeutic Intervention in Cystic Fibrosis Lung Infection and Inflammation.
Hsu D; Taylor P; Fletcher D; van Heeckeren R; Eastman J; van Heeckeren A; Davis P; Chmiel JF; Pearlman E; Bonfield TL
Infect Immun; 2016 Sep; 84(9):2410-21. PubMed ID: 27271746
[TBL] [Abstract][Full Text] [Related]
12. Effect of Pseudomonas infection on weight loss, lung mechanics, and cytokines in mice.
van Heeckeren AM; Tscheikuna J; Walenga RW; Konstan MW; Davis PB; Erokwu B; Haxhiu MA; Ferkol TW
Am J Respir Crit Care Med; 2000 Jan; 161(1):271-9. PubMed ID: 10619831
[TBL] [Abstract][Full Text] [Related]
13. TNF-α is a key regulator of MUC1, an anti-inflammatory molecule, during airway Pseudomonas aeruginosa infection.
Choi S; Park YS; Koga T; Treloar A; Kim KC
Am J Respir Cell Mol Biol; 2011 Feb; 44(2):255-60. PubMed ID: 20448050
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-23-mediated inflammation in Pseudomonas aeruginosa pulmonary infection.
Dubin PJ; Martz A; Eisenstatt JR; Fox MD; Logar A; Kolls JK
Infect Immun; 2012 Jan; 80(1):398-409. PubMed ID: 22025517
[TBL] [Abstract][Full Text] [Related]
15. Role of IL-1β in experimental cystic fibrosis upon P. aeruginosa infection.
Palomo J; Marchiol T; Piotet J; Fauconnier L; Robinet M; Reverchon F; Le Bert M; Togbe D; Buijs-Offerman R; Stolarczyk M; Quesniaux VF; Scholte BJ; Ryffel B
PLoS One; 2014; 9(12):e114884. PubMed ID: 25500839
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Rhesus Theta-Defensin-1 in Experimental Models of Pseudomonas aeruginosa Lung Infection and Inflammation.
Bensman TJ; Jayne JG; Sun M; Kimura E; Meinert J; Wang JC; Schaal JB; Tran D; Rao AP; Akbari O; Selsted ME; Beringer PM
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559270
[TBL] [Abstract][Full Text] [Related]
17. Rationale for development of immunotherapies that target mucoid Pseudomonas aeruginosa infection in cystic fibrosis patients.
Pier GB
Behring Inst Mitt; 1997 Feb; (98):350-60. PubMed ID: 9382760
[TBL] [Abstract][Full Text] [Related]
18. Role of Toll-like receptor 5 in the innate immune response to acute P. aeruginosa pneumonia.
Morris AE; Liggitt HD; Hawn TR; Skerrett SJ
Am J Physiol Lung Cell Mol Physiol; 2009 Dec; 297(6):L1112-9. PubMed ID: 19801452
[TBL] [Abstract][Full Text] [Related]
19. Bioengineered lysozyme reduces bacterial burden and inflammation in a murine model of mucoid Pseudomonas aeruginosa lung infection.
Teneback CC; Scanlon TC; Wargo MJ; Bement JL; Griswold KE; Leclair LW
Antimicrob Agents Chemother; 2013 Nov; 57(11):5559-64. PubMed ID: 23979752
[TBL] [Abstract][Full Text] [Related]
20. Augmented effect of early antibiotic treatment in mice with experimental lung infections due to sequentially adapted mucoid strains of Pseudomonas aeruginosa.
van Gennip M; Moser C; Christensen LD; Bjarnsholt T; Calum H; Jensen PØ; Christophersen L; Hougen HP; Ciofu O; Molin S; Givskov M; Høiby N
J Antimicrob Chemother; 2009 Dec; 64(6):1241-50. PubMed ID: 19815632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
